Shizuoka, Japan

Takashi Seishi

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Kyowa Hakko Kogyo Co., Ltd.. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takashi Seishi. Retrieved from https://idiyas.com/inventor/takashi-seishi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Takashi Seishi

Introduction

Takashi Seishi is a notable inventor based in Shizuoka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address urinary disorders. His work is characterized by a commitment to improving patient care through innovative solutions.

Latest Patents

One of Takashi Seishi's key patents is focused on tricyclic compounds. This invention provides tricyclic compounds that are useful for the treatment of pollakiuria and urinary incontinence. These compounds are represented by a general formula (I), showcasing his expertise in medicinal chemistry.

Career Highlights

Takashi Seishi is associated with Kyowa Hakko Kogyo Co., Ltd., a company known for its advancements in biotechnology and pharmaceuticals. His role at the company has allowed him to contribute to groundbreaking research and development efforts in the industry.

Collaborations

Throughout his career, Takashi has collaborated with esteemed colleagues such as Makoto Yoshida and Shigeru Aono. These partnerships have fostered a collaborative environment that enhances innovation and drives successful outcomes in their projects.

Conclusion

In summary, Takashi Seishi is a distinguished inventor whose work in tricyclic compounds has the potential to significantly impact the treatment of urinary disorders. His contributions to Kyowa Hakko Kogyo Co., Ltd. and collaborations with fellow researchers highlight his dedication to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…